Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment.
暂无分享,去创建一个
Zong-fang Li | L. Henry | M. Nguyen | Y. Yeo | F. Ji | Jie Li | Xuesong Gao | C. He
[1] K. Kerr,et al. Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. , 2018, Journal of hepatology.
[2] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[3] J. Hoang,et al. Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response , 2017, Alimentary pharmacology & therapeutics.
[4] Zong-fang Li,et al. High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy. , 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[5] O. Weiland,et al. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication. , 2017, Journal of hepatology.
[6] T. Ishikawa,et al. Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.
[7] Sheng-Nan Lu,et al. Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy. , 2016, The Journal of antimicrobial chemotherapy.
[8] Peter J. Richardson,et al. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection , 2016, Hepatology.
[9] Zong-fang Li,et al. Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: further evidence in decompensation cirrhosis. , 2013, Journal of hepatology.
[10] William M. Lee,et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. , 2009, Gastroenterology.